T. Rowe Price Associates’s XP XP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107M Buy
5,633,000
+5,434,897
+2,743% +$105M 0.01% 597
2025
Q4
$3.24M Buy
198,103
+11,164
+6% +$197K ﹤0.01% 1550
2025
Q3
$3.51M Buy
186,939
+21,105
+13% +$378K ﹤0.01% 1512
2025
Q2
$3.35M Buy
165,834
+7,492
+5% +$129K ﹤0.01% 1428
2025
Q1
$2.18M Buy
158,342
+13,402
+9% +$185K ﹤0.01% 1569
2024
Q4
$1.72M Buy
144,940
+20,738
+17% +$326K ﹤0.01% 1719
2024
Q3
$2.23M Buy
124,202
+25,817
+26% +$471K ﹤0.01% 1582
2024
Q2
$1.73M Sell
98,385
-4,537,298
-98% -$93.7M ﹤0.01% 1631
2024
Q1
$119M Sell
4,635,683
-294,194
-6% -$7.38M 0.01% 512
2023
Q4
$129M Buy
4,929,877
+293,160
+6% +$6.69M 0.02% 498
2023
Q3
$107M Sell
4,636,717
-44,863
-1% -$1.12M 0.02% 504
2023
Q2
$110M Sell
4,681,580
-5,769,510
-55% -$97.9M 0.02% 506
2023
Q1
$124M Sell
10,451,090
-4,215,006
-29% -$60.1M 0.02% 474
2022
Q4
$225M Sell
14,666,096
-5,686,183
-28% -$99.5M 0.04% 359
2022
Q3
$388M Sell
20,352,279
-1,407,583
-6% -$27.9M 0.06% 259
2022
Q2
$391M Sell
21,759,862
-4,644,127
-18% -$107M 0.05% 336
2022
Q1
$795M Buy
26,403,989
+11,693,326
+79% +$365M 0.08% 240
2021
Q4
$423M Sell
14,710,663
-6,556,651
-31% -$214M 0.04% 376
2021
Q3
$854M Sell
21,267,314
-1,950,639
-8% -$87.1M 0.08% 250
2021
Q2
$1.01B Sell
23,217,953
-1,336,805
-5% -$55.3M 0.09% 225
2021
Q1
$925M Sell
24,554,758
-598,775
-2% -$25.6M 0.09% 237
2020
Q4
$998M Buy
25,153,533
+8,718,091
+53% +$356M 0.1% 208
2020
Q3
$685M Buy
16,435,442
+3,835,059
+30% +$175M 0.08% 255
2020
Q2
$529M Sell
12,600,383
-781,464
-6% -$24M 0.07% 287
2020
Q1
$258M Buy
13,381,847
+5,476,675
+69% +$185M 0.04% 355
2019
Q4
$305M Buy
+7,905,172
New +$297M 0.04% 390

Other funds holding XP

T. Rowe Price Associates's XP Position: Q1 2026 in Review

T. Rowe Price Associates increased its XP (XP) stake by 2,743% in Q1 2026, buying an estimated $105M and bringing the position to 5,633,000 shares worth $107M. The position accounts for 0.01% of the portfolio, ranked #597.

T. Rowe Price Associates first reported a position in XP in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.01B in Q2 2021. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • T. Rowe Price Associates held 5,633,000 shares of XP worth $107M as of Q1 2026.
  • T. Rowe Price Associates bought 5,434,897 XP shares in Q1 2026, an estimated $105M.
  • XP made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #597 holding.
  • T. Rowe Price Associates first reported a position in XP in Q4 2019 and has held it in 26 quarters since.
  • T. Rowe Price Associates's XP position peaked at $1.01B in Q2 2021.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.